{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:27:48Z","timestamp":1759159668085},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.7759\/cureus.50053","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:45:40Z","timestamp":1701884740000},"source":"Crossref","is-referenced-by-count":1,"title":["Adalimumab in the Treatment of Recalcitrant Livedoid Vasculopathy"],"prefix":"10.7759","author":[{"given":"Drishti M","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Bhamburkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Madke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani D","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshiya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040549","article-title":"Adalimumab in treating refractory livedoid vasculopathy","volume":"10","author":"Huang XW","year":"2022","unstructured":"Huang XW, Zheng HX, Wang ML, He WM, Feng MX, Zeng K, Li L. Adalimumab in treating refractory livedoid vasculopathy. Vaccines (Basel). 2022, 10:549. 10.3390\/vaccines10040549","journal-title":"Vaccines (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1012178","article-title":"Livedoid vasculopathy - a diagnostic and therapeutic challenge","volume":"9","author":"Burg MR","year":"2022","unstructured":"Burg MR, Mitschang C, Goerge T, Schneider SW. Livedoid vasculopathy - a diagnostic and therapeutic challenge. Front Med (Lausanne). 2022, 9:1012178. 10.3389\/fmed.2022.1012178","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962011000500015","article-title":"Livedoid vasculopathy: an intringuing cutaneous disease","volume":"86","author":"Criado PR","year":"2011","unstructured":"Criado PR, Rivitti EA, Sotto MN, Valente NY, Aoki V, Carvalho JF, Vasconcellos C. Livedoid vasculopathy: an intringuing cutaneous disease. An Bras Dermatol. 2011, 86:961-77. 10.1590\/s0365-05962011000500015","journal-title":"An Bras Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.183635","article-title":"Livedoid vasculopathy: a review of pathogenesis and principles of management","volume":"82","author":"Vasudevan B","year":"2016","unstructured":"Vasudevan B, Neema S, Verma R. Livedoid vasculopathy: a review of pathogenesis and principles of management. Indian J Dermatol Venereol Leprol. 2016, 82:478-88. 10.4103\/0378-6323.183635","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.4.637","article-title":"Adalimumab: a review of side effects","volume":"4","author":"Scheinfeld N","year":"2005","unstructured":"Scheinfeld N. Adalimumab: a review of side effects. Expert Opin Drug Saf. 2005, 4:637-41. 10.1517\/14740338.4.4.637","journal-title":"Expert Opin Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.4374","article-title":"Treatment for livedoid vasculopathy: a systematic review","volume":"154","author":"Micieli R","year":"2018","unstructured":"Micieli R, Alavi A. Treatment for livedoid vasculopathy: a systematic review. JAMA Dermatol. 2018, 154:193-202. 10.1001\/jamadermatol.2017.4374","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12890\/2023_003727","article-title":"Pain management options in a patient with livedoid vasculopathy and peripheral neuropathy","volume":"10","author":"Palanisamy N","year":"2023","unstructured":"Palanisamy N, Chinnappan J, Bachuwa G. Pain management options in a patient with livedoid vasculopathy and peripheral neuropathy. Eur J Case Rep Intern Med. 2023, 10:003727. 10.12890\/2023_003727","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.11.1413","article-title":"Livedoid vasculopathy: further evidence for procoagulant pathogenesis","volume":"142","author":"Hairston BR","year":"2006","unstructured":"Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol. 2006, 142:1413-8. 10.1001\/archderm.142.11.1413","journal-title":"Arch Dermatol"},{"key":"ref9","article-title":"Adalimumab","author":"Ellis CR","year":"2023","unstructured":"Ellis CR, Azmat CE. Adalimumab. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638444","article-title":"Efficacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis","volume":"12","author":"Lu X","year":"2021","unstructured":"Lu X, Hu R, Peng L, Liu M, Sun Z. Efficacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis. Front Immunol. 2021, 12:638444. 10.3389\/fimmu.2021.638444","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205472-adalimumab-in-the-treatment-of-recalcitrant-livedoid-vasculopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:56Z","timestamp":1707509336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205472-adalimumab-in-the-treatment-of-recalcitrant-livedoid-vasculopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.50053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}